V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 290006528 | 290004892 | null | 67.5 | Adjuvant (A) | 2017-11-27 | 2017-12-03 | Trial Unspecified | 02 | N | 290019331 | PACLITAXEL + TRASTUZUMAB |
| 290006529 | 290007069 | null | 53 | null | 2017-12-28 | 2017-12-28 | OCTREOTIDE | N | N | 290019364 | TRIAL |
| 290006530 | 290004893 | 1.72 | 80 | Palliative (P) | null | 2015-10-09 | MCX | 02 | N | 290019365 | CARBOPLATIN + PACLITAXEL |
| 290006531 | 290004894 | 1.75 | 69.2 | Adjuvant (A) | 2016-05-30 | 2016-11-08 | REGORAFENIB | 02 | Y | 290019376 | CAPECITABINE + OXALIPLATIN |
| 290006532 | 290004895 | 0 | 87.5 | Curative (C) | 2013-12-28 | 2014-01-05 | MCX | 02 | N | 290019383 | CISPLATIN + RT |
| 290006533 | 290004896 | 1.66 | 88.4 | Adjuvant (A) | 2014-12-04 | 2014-12-22 | Capecitabine + Oxaliplatin 21day | null | null | 290019390 | CAPECITABINE + MITOMYCIN + RT |
| 290006534 | 290007073 | 1.71 | 92.1 | Curative (C) | 2013-04-11 | 2013-04-15 | Cisplatin 100 + RT(H&N) 1 day | 02 | null | 290019396 | CAPECITABINE + OXALIPLATIN |
| 290006535 | 290004897 | null | null | Palliative (P) | 2018-03-18 | 2018-03-26 | Irinotecan | N | N | 290019407 | CAPECITABINE + CISPLATIN |
| 290006536 | 290004901 | 1.65 | null | Curative (C) | 2015-08-30 | 2015-09-13 | PEMBROLIZUMAB | N | N | 290019408 | CAPECITABINE |
| 290006537 | 290007074 | 0 | 81.2 | Palliative (P) | 2013-04-25 | 2013-08-08 | CYCLOPHOSPHAMIDE + LENALIDOMIDE | 02 | N | 290019409 | CETUXIMAB + RT |
| 290006538 | 290007074 | 1.71 | 67 | Adjuvant (A) | 2016-03-29 | 2016-05-03 | CETUXIMAB | null | Y | 290019409 | CARBOPLATIN |
| 290006539 | 290004904 | 1.6 | 97 | Palliative (P) | 2016-03-21 | 2016-03-21 | CAPECITABINE + OXALIPLATIN | 02 | N | 290019413 | IRINOTECAN |
| 290006540 | 290004905 | null | 116 | Curative (C) | 2016-07-11 | 2016-07-24 | Capecitabine + Oxaliplatin 21day | 01 | Y | 290019414 | FLUOROURACIL + MITOMYCIN |
| 290006541 | 290004905 | 1.66 | 83 | Adjuvant (A) | 2015-11-29 | 2016-04-08 | Capecitabine + Oxaliplatin 21day | 02 | N | 290019414 | CAPECITABINE + CARBOPLATIN |
| 290006542 | 290004906 | 1.8 | 67 | Curative (C) | null | 2017-08-01 | CETUXIMAB + RT | N | N | 290019428 | CAPECITABINE + MITOMYCIN + RT |
| 290006543 | 290004907 | 1.68 | 70.8 | Palliative (P) | 2016-06-09 | 2016-07-13 | ECX | N | N | 290019428 | CAPECITABINE + RT |
| 290006544 | 290004909 | 2.01 | 65 | Palliative (P) | 2014-12-09 | 2015-01-06 | IRINOTECAN + MDG + PANITUMUMAB | N | N | 290019436 | CARBOPLATIN + ETOPOSIDE |
| 290006545 | 290007077 | 2.01 | 44 | Palliative (P) | 2017-02-17 | 2017-04-19 | Carboplatin+Fluorouracil 4 or 5 day | 2 | N | 290019437 | CAPECITABINE + CISPLATIN |
| 290006546 | 290004910 | 1.76 | 77.7 | Curative (C) | 2013-07-13 | 2013-11-04 | PEMBROLIZUMAB | N | N | 290019455 | CETUXIMAB |
| 290006547 | 290004911 | 1.7 | 33.3 | Palliative (P) | 2015-08-21 | 2015-08-27 | CAPECITABINE + MITOMYCIN + RT | 02 | N | 290019458 | LANREOTIDE |
| 290006548 | 290004912 | 1.9 | 84.4 | Adjuvant (A) | 2017-01-09 | 2017-03-06 | CETUXIMAB | N | N | 290019465 | CARBOPLATIN + PACLITAXEL |
| 290006549 | 290004912 | 1.65 | 88.4 | null | 2017-07-06 | 2017-08-28 | Capecitabine + Oxaliplatin 21day | 02 | Y | 290019465 | LANREOTIDE |
| 290006550 | 290004913 | 1.58 | 69.9 | Curative (C) | 2016-05-20 | 2016-05-21 | PEMBROLIZUMAB | 02 | N | 290019471 | BALLAD TRIAL |
| 290006551 | 290004914 | null | null | Adjuvant (A) | 2014-09-01 | 2014-09-03 | CAPECITABINE + CARBOPLATIN | null | Y | 290019475 | CAPECITABINE + OXALIPLATIN |
| 290006552 | 290004914 | 1.77 | 80 | Curative (C) | 2017-09-28 | 2017-09-28 | CAPECITABINE + MITOMYCIN + RT | null | N | 290019475 | CISPLATIN + RT |
| 290006553 | 290004915 | null | 49.4 | Not known (9) | 2016-11-19 | 2016-11-21 | Capecitabine (14 days)+Carboplatin | 02 | N | 290019481 | CAPECITABINE + MITOMYCIN |
| 290006554 | 290004916 | 1.8 | 66 | Palliative (P) | 2014-04-16 | 2014-05-07 | Capecitabine | N | Y | 290019481 | PEMBROLIZUMAB |
| 290006555 | 290004917 | 1.51 | 53.3 | Adjuvant (A) | 2016-04-01 | 2016-05-23 | Carboplatin + Cetux + FU (Cycle 1) | N | N | 290019485 | CISPLATIN + RT |
| 290006556 | 290004917 | 1.62 | null | Palliative (P) | 2018-04-22 | 2018-04-22 | Trial Unspecified | 2 | N | 290019485 | CAPECITABINE + RT |
| 290006557 | 290004919 | 1.75 | 86.6 | Palliative (P) | 2013-09-17 | 2013-10-02 | Capecitabine + Cisplatin | 02 | N | 290019521 | CETUXIMAB + IRINOTECAN + MDG |
| 290006558 | 290007082 | 1.61 | 83 | Palliative (P) | 2017-09-10 | 2017-09-21 | Capecitabine + Oxaliplatin 21day | 2 | N | 290019528 | CAPECITABINE + CISPLATIN + RT |
| 290006559 | 290004921 | 1.67 | 47 | null | 2017-06-13 | 2017-06-14 | CETUXIMAB + CISPLATIN + FU | 2 | N | 290019537 | SUNITINIB |
| 290006560 | 290004922 | 1.6 | 77.4 | null | 2018-03-14 | 2018-03-14 | LANREOTIDE | 2 | N | 290019537 | CETUXIMAB + OXALIPLATIN + MDG |
| 290006561 | 290004922 | 1.57 | 86 | Adjuvant (A) | 2015-09-02 | 2015-09-02 | LANREOTIDE | 02 | N | 290019537 | CARBOPLATIN + VINORELBINE |
| 290006562 | 290004922 | 1.6 | 0 | Adjuvant (A) | 2014-10-10 | 2014-10-13 | Rituximab | N | N | 290019537 | CETUXIMAB + RT |
| 290006563 | 290004923 | null | 70 | Adjuvant (A) | 2017-10-30 | 2017-11-06 | FLUOROURACIL + Panitumumab | 02 | N | 290019570 | CAPECITABINE + OXALIPLATIN |
| 290006564 | 290004925 | 1.76 | null | Palliative (P) | 2013-06-02 | 2013-07-06 | CETUXIMAB | N | N | 290019577 | CARBOPLATIN + ETOPOSIDE |
| 290006565 | 290004926 | 1.65 | 65 | Curative (C) | 2017-03-05 | 2017-03-17 | Capecitabine + Oxaliplatin 21day | N | N | 290019581 | CARBOPLATIN |
| 290006566 | 290007084 | null | 65.75 | null | 2017-08-26 | 2017-08-26 | Docetaxel | N | Y | 290019591 | CAPECITABINE + RT |
| 290006567 | 290004928 | 1.64 | null | null | 2016-11-27 | 2017-01-01 | Etoposide + Ifosfamide (5 days) | N | N | 290019597 | CAPECITABINE + MITOMYCIN |
| 290006568 | 290004929 | null | null | Curative (C) | 2016-04-15 | 2016-04-28 | Cisplatin + Docetaxel +Fluorouracil | N | N | 290019597 | CISPLATIN + RT |
| 290006569 | 290004931 | 1.63 | 57.8 | Adjuvant (A) | 2017-04-16 | 2017-04-28 | Capecitabine + Streptozocin | 2 | Y | 290019607 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 290006570 | 290004932 | 1.8 | null | Curative (C) | 2018-07-05 | 2018-07-06 | Carboplatin AUC 6 - 10 | 02 | N | 290019621 | TRIAL |
| 290006571 | 290004934 | 1.79 | 76.8 | Curative (C) | 2014-12-28 | 2015-03-25 | MCX | 02 | N | 290019622 | CISPLATIN + RT |
| 290006572 | 290007088 | 1.8 | 94.5 | Curative (C) | 2017-08-06 | 2017-08-13 | Cisplatin 7 day | 2 | N | 290019646 | CETUXIMAB |
| 290006573 | 290004937 | 1.62 | 67.55 | null | null | 2015-04-26 | LANREOTIDE | N | N | 290019647 | CETUXIMAB |
| 290006574 | 290004938 | 1.6 | null | Adjuvant (A) | 2016-11-25 | 2016-12-23 | Cisplatin + Etoposide (3 day) | N | N | 290019648 | CAPECITABINE + OXALIPLATIN |
| 290006575 | 290004940 | 1.64 | 84.8 | Curative (C) | 2017-12-24 | 2017-12-24 | Methotrexate intrathecal | 02 | N | 290019660 | CHOP R |
| 290006576 | 290004941 | null | 75.5 | Curative (C) | 2014-11-24 | 2014-12-12 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | N | 290019674 | CISPLATIN |
| 290006577 | 290004944 | 1.62 | 111 | Curative (C) | 2016-08-07 | 2016-08-07 | Cetuximab + Oxaliplatin + MdG Load | N | Y | 290019692 | COMPARE TRIAL |